<DOC>
	<DOC>NCT01108289</DOC>
	<brief_summary>This study is designed to test the hypothesis that the intramuscular administration of 10 IU of oxytocin in Uniject™ during the third stage of labor by a Community Health Officer (CHO) at home births in Ghana will reduce the risk of postpartum hemorrhage by 50 percent relative to home births attended by the same type of provider who does not provide a uterotonic drug.</brief_summary>
	<brief_title>Effect of Prophylactic Administration of Oxytocin in Uniject™ on Postpartum Hemorrhage at Home Births in Ghana</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>home delivery presence of Community Health Officer at time of delivery</criteria>
	<gender>Female</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>hemorrhage</keyword>
	<keyword>uterotonic</keyword>
	<keyword>oxytocin</keyword>
	<keyword>blood loss</keyword>
	<keyword>community</keyword>
	<keyword>Ghana</keyword>
	<keyword>randomized trial</keyword>
</DOC>